Jul 09,2018

DarioHealth Appoints Healthcare Technology Entrepreneur and Venture Capital Partner Yoav Shaked as Chairman of the Board

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today Yoav Shaked has joined the Company as Chairman of the Board. The Company's Chief Executive Officer, Erez Raphael shall continue serving on the board of directors and as CEO.

View Analyst & Ambassador Comments
Go to original news
Jul 10,2018

First-Year Results from Medtronic and UnitedHealthcare Value-Based Relationship Demonstrate Cost-Savings and Reduced Hospital Admissions

The first-year results reported today are from the measurement period of July 2016 through June 2017 and do not include use of Medtronic's newest insulin pump, the MiniMed 670G system, which was commercially launched at the end of the measurement period. both real-world and clinical trial data on the MiniMed 670G system demonstrate significantly improved Time in Range (the percentage of time spent in the optimal glycemic range of 70-180 mg/dL), A1C (a marker of blood sugar control over time) and Quality of Life for people using the system instead of MDI to manage their Type 1 diabetes.

PRODUCT

#insulin pump

#cgm

View Analyst & Ambassador Comments
Go to original news
Jul 11,2018

Insulet to Announce Second Quarter 2018 Financial Results on August 2, 2018

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced plans to release its financial results for the second quarter of 2018 on August 2, 2018 after the close of the financial markets. In connection with the release, management will host a conference call that day at 4:30 p.m. (Eastern Time).

View Analyst & Ambassador Comments
Go to original news
Jul 12,2018

DarioHealth CEO Erez Raphael's Interview Published in Research 2 Guidance

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that Research2Guidance, an analyst and strategic consulting company for the digital health industry, published an interview of DarioHealth CEO, Erez Raphael titled "Using real-time data to feed predictive care models for diabetes management."

View Analyst & Ambassador Comments
Go to original news
Jul 12,2018

Insulet Extends Partnership with Glooko in Europe to Optimise Diabetes Data Management

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced that it has partnered with Glooko®, Inc. to connect Insulet’s Omnipod System user data with Glooko+diasend®, the most comprehensive diabetes data management system available, across Europe.

COLLABORATION PARTNERSHIP

#connected device

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Jul 16,2018

Tandem Diabetes Care Schedules Second Quarter 2018 Earnings Press Release and Conference Call

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, plans to release its second quarter 2018 results after the financial markets close on Monday, July 30, 2018.

View Analyst & Ambassador Comments
Go to original news
Jul 17,2018

CeQur Acquires Assets from Calibra Medical, Inc.

CeQur® today announced that the company has acquired select assets of Calibra Medical, Inc., one of the Johnson & Johnson Diabetes Care Companies. The transaction includes an exclusive worldwide license for the wearable, on-demand insulin delivery system previously known as OneTouch Via™.

COLLABORATION MERGERS & ACQUISITION

#product & service

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Jul 17,2018

Nemaura Places SugarBEAT® Manufacturer Order for UK Commercial Launch

Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing the wireless sugarBEAT® non-invasive glucose monitoring system for adjunctive use by persons with diabetes, today announced it has placed an initial order with its designated UK-based contract manufacturer for 12,500 sugarBEAT® rechargeable transmitters, which will be supplemented with approximately 100,000 skin-patches per month, also manufactured in the UK, in preparation for the anticipated sugarBEAT® product launch in the coming months.

PRODUCT

#cgm

View Analyst & Ambassador Comments
Go to original news
Jul 25,2018

DarioHealth Launches New Annual Membership & Product Enhancements to Promote Long-Term Use, Higher Levels of User Engagement, and Associated Sustainable Behavioral Changes

DarioHealth recently announced very compelling data from over 17,000 people who used its integrated digital health solution in 2017. Users with Type 2 diabetes saw a 19% reduction in the average ratio of high glucose events and an 11% increase in the ratio of normal range readings. The data also showed even higher improvement in glucose levels with sustainable results when users were on the system for a year or more.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Jul 25,2018

Fit4D (now Cecelia Health) and Humana to Co-Present at the AADE National Conference in Baltimore

Fit4D, a New York City-based diabetes management company and now named as Cecelia Health, today announced that its CEO David Weingard and Clinical Director Brooke Benton will join Humana Inc.’s (NYSE: HUM) Bold Goal Director Dr. Andrew Renda on the main stage at this year’s annual American Association of Diabetes Educators (AADE) conference to discuss how value can be delivered for patients, providers and payers.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES